BLO — Cannabix Technologies Share Price
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro CapFalling Star
- CA$39.95m
- CA$32.66m
- 63
- 16
- 23
- 24
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.28 | ||
| Price to Tang. Book | 5.28 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | n/a | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -45.39% | ||
| Return on Equity | -39.02% | ||
| Operating Margin | n/a | ||
Financial Summary
| Year End 30th Apr | Unit | 2018 | 2019 | 2020 | 2021 | 2022 | 2023E | 2024E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Cannabix Technologies Inc. is a developer of marijuana breathalyzer technologies through research and development activities and licensing of certain technologies. The Company is engaged in developing breath testing technologies that can be used at the point of care to detect recent use of marijuana. Its FAIMS device is designed to operate both independently or coupled in tandem directly to a mass spectrometer (MS), used in forensic labs. The FAIMS device is used in combination with the breath collection unit. It has developed the Breath Collection Unit (BCU) for the collection of breath samples at the point of care. Its THC Breath Analyzer (THCBA) is a point of care breath testing tool for the rapid detection of recent cannabis use. THCBA collects a single breath from the user and the sensor response is represented by a characteristic pattern or smell-print to the specific target gas. It also offers contactless alcohol breathalyzer (CAB) for workplace and business.
Directors
- Kulwant Malhi PRE (52)
- Ravinder Mlait CEO (45)
- Bryan Loree CFO (44)
- Rajpaul Attariwala IND
- Thomas Clarke IND (43)
- Last Annual
- April 30th, 2022
- Last Interim
- October 31st, 2022
- Incorporated
- April 5th, 2011
- Public Since
- December 16th, 2013
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Canadian Securities Exchange
- Shares in Issue
- 114,144,104
- Address
- 501-3292 Production Way, BURNABY, V5A 4R4
- Web
- http://www.cannabixtechnologies.com/
- Phone
- +1 6045517831
- Auditors
- Saturna Group LLP
Upcoming Events for BLO
Similar to BLO
Aquarius Surgical Technologies
Canadian Securities Exchange
Bloom Health Partners
Canadian Securities Exchange
Cognetivity Neurosciences
Canadian Securities Exchange
Gemina Laboratories
Canadian Securities Exchange
Izotropic
Canadian Securities Exchange
FAQ
What is the Cannabix Technologies share price?
As of Today at 24:03 UTC, shares in Cannabix Technologies are trading at CA$0.35. This share price information is delayed by 15 minutes.
How has the Cannabix Technologies share price performed this year?
Shares in Cannabix Technologies last closed at CA$0.35 and the price had moved by -38.6% over the past 365 days. In terms of relative price strength the Cannabix Technologies share price has underperformed the Toronto Stock Exchange 300 Composite Index by -31.05% over the past year.
What are the analyst and broker recommendations for Cannabix Technologies?
There is no consensus recommendation for this security.
What is the Cannabix Technologies dividend yield?
Cannabix Technologies does not currently pay a dividend.
Does Cannabix Technologies pay a dividend?
Cannabix Technologies does not currently pay a dividend.
When does Cannabix Technologies next pay dividends?
Cannabix Technologies does not currently pay a dividend.
How do I buy Cannabix Technologies shares?
To buy shares in Cannabix Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cannabix Technologies?
As of the previous close price of CA$0.35, shares in Cannabix Technologies had a market capitalisation of CA$39.95m.
Where are Cannabix Technologies shares listed?
Here are the trading details for Cannabix Technologies:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: BLO
What kind of share is Cannabix Technologies?
Based on an overall assessment of its quality, value and momentum Cannabix Technologies is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cannabix Technologies share price forecast for 2023?
We could not find analyst target price data for this security.
What is the trend in the Cannabix Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cannabix Technologies. Over the past six months, its share price has outperformed the Toronto Stock Exchange 300 Composite Index by +13.24%.
As of the last closing price of CA$0.35, shares in Cannabix Technologies were trading -17.7% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cannabix Technologies PE Ratio?
The Cannabix Technologies PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cannabix Technologies?
Cannabix Technologies' management team is headed by:
- Kulwant Malhi - PRE
- Ravinder Mlait - CEO
- Bryan Loree - CFO
- Rajpaul Attariwala - IND
- Thomas Clarke - IND